Pharmafile Logo

FDA Map

FDAMAP is a group of global healthcare experts that conducts highly informative conferences, workshops and other training sessions for pharma, diagnostics and medical device industry professionals. Our panels of speakers include experts in clinical trials, data management, statistics, regulatory affairs, safety reporting, pharmacovigilance, social media marketing of medical products (drugs, biologics and medical devices), project management, GMP, GCP GLP, FDA/EMA audits, and information technology. Learn more about our Training and Consultancy Programs (Regulatory Workshops, FDA Seminars and Conferences, and Regulatory Consultancy) on our website www.fdamap.com

We work with professionals, regulators, and government agencies to build unique platforms for consultation, training, networking, and professional development. We strive hard to make high quality, mutually beneficial relationships with our customers and partners alike.

The FDAMap initiative is the newest venture of a group of leading experts from the industry and government to bring professionals at all levels together to create best practices based on logic, logistics, legal, and least-burdensome compliance. Visit: www.fdamap.com

This is a FREE LISTING on PMHUB

Below are full profiles from other companies in related areas

Genesis Research Group

Genesis Research Group empowers life science companies to innovate differently by fundamentally transforming the way they engage with research partners. Through the integration of robust stakeholder insights (RPR), data-agnostic expertise,…

View Profile

Company Details

20203 Goshen Rd,, Suite 261 Gaithersburg, Gaithersburg, Maryland, MD 20879, United States
+1-410-501-5777

 Latest Content from PMHub 

Oxford University Press advertising and custom content team hosts their first ever virtual drop-in sessions

This is your chance to ask Oxford University Press anything: a quick question about advertising deadline dates for the European Heart Journal or a full presentation on the benefits of...

An update from Oxford University Press Advertising and Corporate Services

Angela Joines, our advertising and reprints manager in Cary, North Carolina, has recorded a quick message to give you a glimpse of how we’re getting on working remotely in these...

Creative med affairs and bridging the healthcare gap

Within the healthcare industry, any patient-facing activity has traditionally been the domain of marketing teams – be that brand marketing or marketing individual products. Recently, however, a trend has emerged...

How can pharma align its brand strategy with the NHS Reset?

Oli Hudson, of Wilmington Healthcare, explores how pharma should respond to plans to ‘reboot’ the NHS during the covid recovery era

Commercial Execution Strategies During & After the Pandemic

Frank Armenante, Director of Commercial Execution at Novo Nordisk, discusses a range of topics, from the impact of COVID-19 on commercial operations and the digitization of Pharma to his leadership lessons...

A Lucid Group Thirsty Thursday: change management and self-efficacy

Last week, Lucid Group were lucky enough to have Richard Nugent, Founder and Managing Director of TwentyOne Leadership, present a session on change management and self-efficacy. Richard often works with...

Lucid Group expand its UK office footprint in Macclesfield

Lucid Group is increasing its share of office space on the popular Tytherington Business Village, after a sustained period of growth, which has seen it outperform a buoyant marketplace and taken...

How does nature influence wellbeing and refocus the mind?

Time is the 21st century's most precious commodity – we all live in a world where rushing around seems more normal than having a relaxing coffee break

Article

White Papers and Resources | October 30, 2020 | Inizio

How will COVID-19 affect uptake of vaccinations against other diseases?

Top 10 Reasons Why Virtual Collaboration and Medical Education Will Persist in the New Normal

Even after the pandemic is long behind us, virtual collaboration will become mainstay in Pharma.